Skip to main navigation
Skip to search
Skip to main content
Luxembourg Institute of Health Home
Search content at Luxembourg Institute of Health
Home
Profiles
Research units
Research output
Projects
Equipment
Datasets
Transplants for Glioblastoma
Jian Wang
*
, A. J.A. Terzis
, Karen S. Aboody
, Per Oyvind Enger
, Rolf Bjerkvig
*
Corresponding author for this work
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Transplants for Glioblastoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Glioblastoma
100%
Primary Brain Tumor
100%
Gene Therapy
50%
Glioma
50%
Viral Vectors
50%
Cell-based
50%
Necrosis
50%
Treatment Modalities
50%
Treatment Principles
50%
Glioblastoma multiforme
50%
Cell Therapy
50%
Glioma Growth
50%
Chemotherapy
50%
Radiotherapy
50%
Adoptive Transfer
50%
Growth Hormone Receptor
50%
Therapeutic Vaccine
50%
Anti-angiogenesis
50%
Activated Lymphocytes
50%
Intracranial Neoplasm
50%
Vascular Proliferation
50%
Neoplastic Cells
50%
Dismal Prognosis
50%
Neuroglial Cells
50%
Antisense Inhibition
50%
Suicide Treatment
50%
Tumor Growth Factor
50%
Thymidine Kinase
50%
Poor Differentiation
50%
Tumor Growth Inhibition
50%
Glioma Progression
50%
Medicine and Dentistry
Glioblastoma
100%
Intracranial Tumor
100%
Ganglioglioma
66%
Cell Therapy
66%
Diseases
66%
Adoptive Transfer
33%
Antiangiogenic Activity
33%
Necrosis
33%
Virus Vector
33%
Immunotherapy
33%
Microglia
33%
Thymidine Kinase
33%
Growth Factor Receptor
33%
Gene Therapy
33%
Lymphocyte
33%
Cancer Growth Factor
33%
Radiation Therapy
33%
Chemotherapy
33%
Treatment Modality
33%